The Commodity Futures Trading Commission said it ordered Piper Sandler to pay a $2 million fine to settle charges against the company's introducing broker for failing to meet recordkeeping ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

Piper Sandler analysts are cautioning investors about a potential correction in the S&P 500, despite recent highs. Their note highlights a weakening market that could lead to a significant pullback.

In a recent note, Piper Sandler chief investment strategist Michael Kantrowitz responded "So what?" to other strategists' skepticism and calls for bearishness as S&P 500 (^GSPC) valuations climb ...

JMP Securities analyst Devin Ryan maintained a Hold rating on Piper Sandler (PIPR – Research Report) today. The company’s shares closed last Friday at $280.53. According to TipRanks ...

Piper Sandler initiated coverage of Camp4 Therapeutics (CAMP) with an Overweight rating and $18 price target The company is is pioneering development of regulatory RNAs as a novel therapeutic ...

In a reminder that stretched valuations make for poor timing signals, Piper Sandler strategist Michael Kantrowitz observed in a Monday note that the S&P 500 is overvalued to the tune of around 8% ...

Piper Sandler analyst Brad Capuzzi raised the firm’s price target on LendingClub (LC) to $15 from $13 and keeps an Overweight rating on the shares following Q3 earnings. The firm notes ...

Piper Sandler Companies (NYSE:PIPR), a leading investment bank and institutional securities firm, has demonstrated resilience and strategic growth in a dynamic financial landscape. The company's ...

Piper Sandler analyst Harsh Kumar lowered the firm’s price target on Qorvo (QRVO) to $85 from $100 and keeps a Neutral rating on the shares. The firm notes Qorvo reported September quarter ...

ANI Pharmaceuticals (NASDAQ:ANIP) traded higher in the premarket trading on Friday after Piper Sandler launched its coverage with an overweight recommendation and a $68 per share target ...